Review
Published on 31 Jul 2023
Targeting nuclear hormone receptors for the prevention of breast cancer
in Translational Medicine
Frontiers in Medicine
doi 10.3389/fmed.2023.1200947
- 6,575 views
- 17 citations
46 articles related to "Progesterone Receptor Pr"
Articles
Case Report
Published on 14 Feb 2023
Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1023787
- 3,688 views
- 2 citations
Review
Published on 12 Nov 2020
Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.563779
- 14,837 views
- 30 citations
Mini Review
Published on 16 Jun 2021
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.681476
- 32,059 views
- 154 citations
Case Report
Published on 20 Feb 2025
Breast acinic cell carcinoma with weak progesterone receptor expression: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1497272
- 2,484 views
- 2 citations
Original Research
Published on 11 Dec 2020
Meningiomas in Premenopausal Women: Role of the Hormone Related Conditions
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.556701
- 14,867 views
- 23 citations
Original Research
Published on 04 May 2016
Phemindole, a Synthetic Di-indole Derivative Maneuvers the Store Operated Calcium Entry (SOCE) to Induce Potent Anti-Carcinogenic Activity in Human Triple Negative Breast Cancer Cells
in Cancer Molecular Targets and Therapeutics
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00114
- 6,778 views
- 31 citations
Original Research
Published on 22 Jan 2020
DeepSnap-Deep Learning Approach Predicts Progesterone Receptor Antagonist Activity With High Performance
in Computational Genomics
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2019.00485
- 9,487 views
- 22 citations
Original Research
Published on 05 Apr 2022
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.797873
- 4,645 views
- 11 citations
Original Research
Published on 02 Aug 2019
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
in Cancer Metabolism
Frontiers in Oncology
doi 10.3389/fonc.2019.00686
- 19,526 views
- 54 citations
Review
Published on 22 Sep 2025
Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1645438
- 5,409 views
Original Research
Published on 10 Nov 2022
Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.974487
- 5,037 views
- 7 citations
Original Research
Published on 07 Nov 2019
Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2019.02617
- 7,174 views
- 6 citations
Original Research
Published on 07 May 2019
Ligand Binding Induces Agonistic-Like Conformational Adaptations in Helix 12 of Progesterone Receptor Ligand Binding Domain
in Theoretical and Computational Chemistry
Frontiers in Chemistry
doi 10.3389/fchem.2019.00315
- 5,089 views
- 9 citations
Original Research
Published on 08 Dec 2021
Diet, Sports, and Psychological Stress as Modulators of Breast Cancer Risk: Focus on OPRM1 Methylation
in Nutritional Epidemiology
Frontiers in Nutrition
doi 10.3389/fnut.2021.747964
- 3,968 views
- 8 citations
Original Research
Published on 02 Jun 2022
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.820437
- 6,130 views
- 7 citations